chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BAD DIARRHEA; This spontaneous case (PVX2019-1155) was received from nurse on 09-May-2019. It describes a 31-year-old female consumer who experienced bad diarrhea, after the administration of oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer experienced bad diarrhea after taking first dose of Vivotif in this week. Apart from taking probiotic, she did not take treatment for the event.   Action taken with Vivotif was unknown.  The consumer had been recovering from the event.  Company's Comment: In this case, it was reported that the consumer had bad diarrhea, after the administration of oral Vivotif. There seems to be a temporal association between the intake of the vaccine and the event. Also, diarrhoea is labelled as per CCDS. Hence, the causality of the event with Vivotif is assessed as possible.; Sender's Comments: Company's Comment: In this case, it was reported that the consumer had bad diarrhea,  after the administration of oral Vivotif. There seems to be a temporal association between the intake of the vaccine and the event. Also, diarrhoea is labelled as per CCDS. Hence, the causality of the event with Vivotif is assessed as possible.
Flu symptoms started immediately after 1st Anthrax shot.  High fever, coughing, congestion, headaches
short of breath; coughing up foam that is up in her chest and lungs; inflammation that are all ongoing; lost 68 pounds; fever to 102; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (short of breath), COUGH (coughing up foam that is up in her chest and lungs), INFLAMMATION (inflammation that are all ongoing), WEIGHT DECREASED (lost 68 pounds) and PYREXIA (fever to 102) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (short of breath), COUGH (coughing up foam that is up in her chest and lungs), INFLAMMATION (inflammation that are all ongoing), WEIGHT DECREASED (lost 68 pounds) and PYREXIA (fever to 102). At the time of the report, DYSPNOEA (short of breath), COUGH (coughing up foam that is up in her chest and lungs), INFLAMMATION (inflammation that are all ongoing), WEIGHT DECREASED (lost 68 pounds) and PYREXIA (fever to 102) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.   This case was linked to MOD-2021-263909 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up information received on 22-JUL-2021 and contains General tab - Phone number, address Events tab - Newevents added.Consent to follow up-Yes
After second shot of Moderna on 03/14 I developed Uveitis in my left eye that lead to vision being diminished, I was prescribed a course of steroid (drops) and the issue subsided after several months. I do still have scarring in my eye that causes floaters. I had the booster shot on 11/22, I developed acute hives 8 days later. I have no history of allergies or hives. I have been prescribed antihistamines to treat the hives, Sharing this as I've never had adverse reactions to other vaccines or medication am healthy and don't take other medication. It appears that in both cases my body is triggering an immune response that is causing inflammation (beyond what the vaccine is supposed to do).
high flu or high-dose fluzone given to a pregnant person with no reported adverse event; Initial information received on 13-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age pregnant female patient who was given influenza quadrival a-b high dose hv vaccine [fluzone high-dose quadrivalent]. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known and occurred at unknown gestation period.  The date of last menstrual period was not reported. The estimated due date was not reported.  The patient's previous pregnancies details were not provided.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received 0.7 ml dose of suspect influenza quadrival a-b high dose hv vaccine lot number not reported via unknown route in unknown administration site (route, formulation, strength and expiration date: not provided) for Immunisation (exposure during pregnancy) (latency- same day)  Action taken- not applicable.  At time of reporting, the outcome was Unknown for the event and Additionally, at time of reporting, the outcome of the pregnancy is unknown.
Patient reported that by 6p.m. the same evening of the vaccine, her arm had pain and she had declined range of motion (eg trouble pulling up pants, difficulty lifting arm to wash hair).  Patient still had pain and trouble raising her arms forwards and backwards with weakness a week later.
Son has fever of 102.3 now. Was given tylenol 5 hours ago. Is sleeping now.
My left wrist is hurting, and it gives out; On my right side, I am having really sharp pains; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included High cholesterol (Patient was taking cholesterol medication) since an unknown date. Concomitant products included VITAMIN E NOS, FISH OIL, GARLIC [ALLIUM SATIVUM] and METOPROLOL TARTRATE for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains). At the time of the report, ARTHRALGIA (My left wrist is hurting, and it gives out) and PAIN (On my right side, I am having really sharp pains) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included unspecified cholesterol medication.  The patient did not receive any treatment medication  3-5 hours after the vaccine the symptoms started. Her left wrist is hurting, when she picks something up, it gives up and she drops whatever she is holding. It goes on and off. On her right side, she was having really sharp pains, every 30 min-1 hours.
received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired vaccine) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired vaccine). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (received expired vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Nov-2020, SARS-CoV-2 test: positive (Positive) positive. In December 2021, Vital signs measurement: stable (normal) Stable.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (received expired vaccine) to be not related.    Concomitant information was not reported. Treatment information was not reported.  Patient reported that there were no complaints, left arm without redness, swelling or bruising positive ROM.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2021: Updated patient demographics. Added lab test and dosage details. Updated reporter causality. On 27-Dec-2021: Follow up information included no new information.
It has been 10 days and "I" still do not feel well; "I" keep getting vertigo to the point that "I" have to catch myself so "I" do not fall over. "I" got up at 6 AM and by 7:30 "I" felt awful.; "My" entire body ached, "I" had an awful migrane and a low grade fever; "My" entire body ached, "I" had an awful migrane and a low grade fever; "My" entire body ached, "I" had an awful migrane and a low grade fever; "I" was exhausted and could barely think straight or even carry a conversation; During the night, was woken up by how sore arm was. During the night, was woken up by how sore arm was; This is a spontaneous report from a non-contactable reporter (consumer or other non-HCP). The reporter is the patient. A 31-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Jan2022 at 16:45 (Lot number: FK9729) at the age of 31 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19? Yes. There were no concomitant medications. Past drug history included: Naproxen, reaction(s): "Drug allergy", notes: Known allergies: Naproxen. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 29Jan2022, outcome "not recovered", described as "During the night, was woken up by how sore arm was"; SLEEP DISORDER (non-serious) with onset 29Jan2022, outcome "not recovered", described as "During the night, was woken up by how sore arm was"; FEELING ABNORMAL (non-serious) with onset 29Jan2022 at 07:30, outcome "not recovered", described as ""I" got up at 6 AM and by 7:30 "I" felt awful"; PAIN (non-serious), MIGRAINE (non-serious), PYREXIA (non-serious), all with onset 29Jan2022 at 07:30, outcome "not recovered", described as ""My" entire body ached, "I" had an awful migrane and a low grade fever"; FATIGUE (non-serious) with onset 29Jan2022 at 07:30, outcome "not recovered", described as ""I" was exhausted and could barely think straight or even carry a conversation"; MALAISE (non-serious) with onset an unknown date in Feb2022, outcome "not recovered", described as "It has been 10 days and "I" still do not feel well"; VERTIGO (non-serious) with onset an unknown date in Feb2022, outcome "not recovered", described as ""I" keep getting vertigo to the point that "I" have to catch myself so "I" do not fall over". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity, sleep disorder, feeling abnormal, pain, migraine, pyrexia, fatigue, malaise and vertigo.Additional information: Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.No follow-up attempts are possible. No further information is expected.
Patient taken to ED by EMS after COVID vaccine. Patient with SOB, dizziness, and HA after first COVID vaccine.
One hour after vaccine, left arm swollen and sore.  Progressively got worse with extreme pain and hives on arm and shoulder.  Also experienced headache, dizziness, sore eyes.  Took Benadryl and Tylenol.  Symptoms improving.
Approximately 1 week following vaccination the patient developed daily fever up to 103° F, diffuse joint pain and myalgia, severe headache, drenching night sweats, and fatigue.  The symptoms persisted for 8 weeks prior to presentation to my office with prior workup at previous PCP.  She ultimately developed erythematous nodular rash in addition to the above symptoms.  I obtained a punch biopsy of this and it resulted with findings of neutrophilic dermatosis consistent with either palisaded neutrophilic dermatitis or possibly consistent with Sweet's syndrome.  The patient was started on prednisone for this and had initial improvement in rash but had subsequent relapse.  At this time she has been referred to Rheumatology, Dermatology and Neurology.  She has been initiated on dapsone for attempted steroid sparing regimen for treatment of her rash however she continues to have daily fever, headache and night sweats.
Diagnosed with COVID-19 after vaccination. Patient was sent to the ED by her PCP for monoclonal antibody therapy (received casirivimab/imdevimab on 8/4), but was subsequently admitted (hypoxic, satting 89% on room air). Her symptoms consisted of  cough, decreased PO intake, and worsening weakness. She was started on 2L of oxygen via nasal cannula. She is receiving dexamethasone 6 mg PO daily (on day 4 of 10), remdesivir 200 mg IV x 1 followed by 100 mg IV x 4 additional days (on day 4 of 5). On 8/7, her oxygen requirement increased to 5L and she reported feeling fatigue and experiencing non-productive cough. Today, she is on 6L of oxygen and is still admitted.
Onset of fever, headache, gut distress - symptoms continued for roughly 24 hours.
cried for 3 hrs almost continuously inconsolable, legs reddened & swollen @ site of DTP inject; no fever; pt seen by MD;
This spontaneous report was received from a office manager and a company representative and refers to a 74 year old female patient. The patient's medical history and concomitant therapies were not provided. There were no known allergies. On 11-JUN-2018, the patient was vaccinated with a properly stored PNEUMOVAX 23 1 injection, intramuscularly in the left deltoid, lot # R009408, expiration date on 07-MAR-2020 for prophylaxis. The reporter stated that on 13-JUN-2018, the patient noted that their left arm became swollen, warm and itchy with purple/red markings noted from the armpit down to the elbow. Therefore, the patient sought medical attention and visited the physician's office. The patient was treated with unspecified therapies. The outcome of feeling hot, peripheral swelling, erythema and pruritus was reported as recovering. The reporter did not provide causality assessment between the events and PNEUMOVAX 23.
At approx. 5:00pm on 4/15/21 I started to get a nose bleed. Bled lasted approx. 5-8mins and was small to medium flow (napkin of two). Bleeding stopped for approx. 5 mins and started a second time. Second bleed lasted approx. 6-10mins and was a medium to heavy flow (4-5 napkins). When I was able to wash out the blood a large blood slime was pulled out from my nose. All bleeding was from the right nostril.  No bleeding has occurred since (approx. 15hrs later).
the injection site is warm to touch; soreness at the injection site; area of a few mm surrounding the injection site-no erythema; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE ERYTHEMA (area of a few mm surrounding the injection site-no erythema) and VACCINATION SITE WARMTH (the injection site is warm to touch) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20a) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE ERYTHEMA (area of a few mm surrounding the injection site-no erythema) and VACCINATION SITE WARMTH (the injection site is warm to touch). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE ERYTHEMA (area of a few mm surrounding the injection site-no erythema) and VACCINATION SITE WARMTH (the injection site is warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided Treatment information was not provided
Received Td booster 1/29/03. Experienced mild tenderness at site. Started feeling "off balances". 2/2/03 sensation of "falling backward". Feeling abated. Received MMR on 2/3/03. 1 wk later on 2/10/03 dizziness returned "like a freight trash". Went to an immediate care facility and put on Meclizine Beserred to ENT for evaluation. All tests negative. Primary MD ran other blood tests - all negative for mono, lupus, Lyme disease. Currently experiencing extreme muscle fatigue in both legs and left arm.
Pt here, c/o pain to (L) upper arm, decreased mobility, pain at arm pit itching last night with cough and chest tightness last night after receiving pneumococcal vaccine polyvalent (PNEUMOVAX 23) in (L) arm 10/2/14. Pt c/o enlarged, painful lymph nodes (L) under arm. Pt reports had influenza vaccine 1 month before this date. No HA; Afebrile at 97.5 today. Decreased mobility to (L) arm. Pt exhibited decreased mobility (L)(L) arm; no enlarged lymph nodes palpated upon exam.
I stayed for 15 minutes for observation.  Maybe 15 minutes later as we were driving home my lips were numb.. then five  minutes later my tongue was numb, and then my throat felt like I had swollen glands. We went to ER closest to where we were
Back and body ache, legs groin chest, kidneys, throw up and fever. Went to emergency, Doctors took many many test
Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 95 years of age and did not receive 2nd dose of vaccine. elected hospice service on 3/9/21. Medically unable to get 2nd dose, declined per wife and not interested. PMH significant for hyperlipidemia, cerebral infarction, htn, CAD, CKD, squamous cell carcinoma, COPD, malignant melanoma of scalp.
Cellulitus, fever, chills, body ache, back ache, lymphadenitis.
Body aches and swollen glands under left arm for first 28 hrs.  After 28 hrs fever built up to 101.2 along with rapid heart beat, increased body aches, pounding heart and sweating.  Symptoms lessoned in the morning.  Fever returned the next evening (Friday 1/15).  Cleared by Saturday except for tiredness.  Entire episode completed by Saturday morning 1/16/21.  No hospitalization or MD visit. Would have visited my Primary MD, but they referred me to the organization administering the vaccine.  Vaccine was given out at work, there isn't a medical clinic available for employees.
ADACEL (Tdap) given 7/8/10 (L) Deltoid called 7/12/10 to c/o she went to Urgent Care 7/11/10 due to pain, redness and swelling at inj site given antibiotic KEFLEX, BACTRIM and ROCEPHIN inj on 7/10/10 and 7/11/10 at urgent care.
bump; redness; feels warm; hard; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (bump), ERYTHEMA (redness), SKIN WARM (feels warm) and MUSCULOSKELETAL STIFFNESS (hard) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METFORMIN and INSULIN for Diabetes mellitus, LISINOPRIL for Hypertension.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced SWELLING (bump), ERYTHEMA (redness), SKIN WARM (feels warm) and MUSCULOSKELETAL STIFFNESS (hard). At the time of the report, SWELLING (bump), ERYTHEMA (redness), SKIN WARM (feels warm) and MUSCULOSKELETAL STIFFNESS (hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  treatment to the events not provide.
Within 1 minute post vaccination, patient reported nausea, not feeling well. Exam revealed bradycardia, hypotension, resolved with laying supine 30 min.
Patient initially felt a little short of breath but went away quickly. Patient called and came in 6/20/18 and stated arm has been warm to touch and it is visbually swollen around injection site. Patient states arm has been sore to move. Patient states she is feeling better. Symptoms are going away slowly.
First I had a mucous thick bloody discharge then a few days later a bloody discharge similar to my period. This continued for several days of and on for several weeks. I made a doctors appointment and was referred to a Gynecologists, on 12/07/2022 a pap smear was performed and an abnormal result was noted.
between 3 to 4 days after receiving her Moderna booster, patient had what I suspect was a syncopal episode.  She fell, fractured several ribs and sustained a concussion.  She was admitted to the hospital to trauma service and had full metabolic evaluation and imaging studies which only showed rib fractures but no other serious injuries of the head chest or abdomen.  Patient did not have complete memory of events even a week after the event.  She is otherwise recovering well without any long-term sequelae.
Client reports tingling in arms, face, hands down to feet and felt lightheaded and dizzy. Client reports lasting about an hour, increased then plateaued and then decreased with taking Benadryl.  Similar circumstances with first vaccination lasting approximately 1.5 hours.  Increased heart rate and increase blood pressure during both circumstances.
Pt called office and described localized redness, soreness, mild swelling of L arm with difficulty lifting arm. Pt describes the reddened area to be about 6 inches around. Pt denies fevers, headaches or any other generalized symptoms. Pt's aunt who was given permission to speak on her behalf on the phone by the pt stated that the reddened area was only about 1 inch around and denied any streaking. Pt then called on 5/19/16 and stated that she was seen by her allergist for the reaction and was given recommendation on receiving subsequent doses of the Trumenba vaccine, but upon calling to request a report from the visit our office was informed that she was not seen there for this concern.
I had a bad cough and shortness of breath. I went to the doctor and they diagnosed me with RSV. They did 2 Covid tests and both came out negative. I came out positive for RSV. They gave me erythromycin and Prednisone.
Post vaccination, on 08/08/2001 the patient began with symptoms of toxic synovitis. The next week the symptoms worsened. On 08/17/2001 the patient developed a petechial rash. The patient's labs and symptoms were improving by 08/22/2001.
Pt experienced hives, welts at the injection area (red, sore,hot to touch--area about size of a hand), pain from elbow to shoulder, no fever (98 F).  Pt said size of redness increased over time and pain progressed to wrist to top of neck.  Pt went to urgent care the evening of 11/10/20, was given a prescription for cephalexin for 10 days and told she had cellulitis from the flu vaccination being given too low on the arm.  Pt saw PCP the next morning , 11/11/20, and will follow up with PCP after finishing course of antibiotics (she had taken 2 doses of cephalexin at the time of interview, afternoon of 11/11/20, and symptoms remained).  Pt said she had not had a problem with flu vaccines, but did have severe flu symptoms for a couple of weeks starting a few days after a flu vaccine in 11/2017.  The timing of when the symptoms appeared in relation to the 11/17 flu shot was not clear, but the pt said she was under a lot of stress at the time and may have contracted the flu.